NM_016169.4:c.50C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_016169.4(SUFU):​c.50C>T​(p.Ala17Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000305 in 1,590,980 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A17P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

SUFU
NM_016169.4 missense

Scores

2
3
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:3

Conservation

PhyloP100: 2.53

Publications

6 publications found
Variant links:
Genes affected
SUFU (HGNC:16466): (SUFU negative regulator of hedgehog signaling) The Hedgehog signaling pathway plays an important role in early human development. The pathway is a signaling cascade that plays a role in pattern formation and cellular proliferation during development. This gene encodes a negative regulator of the hedgehog signaling pathway. Defects in this gene are a cause of medulloblastoma. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
SUFU Gene-Disease associations (from GenCC):
  • medulloblastoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Genomics England PanelApp, Orphanet
  • basal cell nevus syndrome 2
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • ocular motor apraxia, Cogan type
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • Joubert syndrome 32
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Joubert syndrome
    Inheritance: AD, AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • apraxia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • ciliopathy
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.024481624).
BP6
Variant 10-102504202-C-T is Benign according to our data. Variant chr10-102504202-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 413907.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000263 (40/152240) while in subpopulation AMR AF = 0.000458 (7/15298). AF 95% confidence interval is 0.000231. There are 0 homozygotes in GnomAd4. There are 21 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016169.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUFU
NM_016169.4
MANE Select
c.50C>Tp.Ala17Val
missense
Exon 1 of 12NP_057253.2
SUFU
NM_001178133.2
c.50C>Tp.Ala17Val
missense
Exon 1 of 11NP_001171604.1Q9UMX1-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUFU
ENST00000369902.8
TSL:1 MANE Select
c.50C>Tp.Ala17Val
missense
Exon 1 of 12ENSP00000358918.4Q9UMX1-1
SUFU
ENST00000423559.2
TSL:1
c.50C>Tp.Ala17Val
missense
Exon 1 of 10ENSP00000411597.2Q9UMX1-3
SUFU
ENST00000369899.6
TSL:1
c.50C>Tp.Ala17Val
missense
Exon 1 of 11ENSP00000358915.2Q9UMX1-2

Frequencies

GnomAD3 genomes
AF:
0.000263
AC:
40
AN:
152130
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000228
AC:
47
AN:
206434
AF XY:
0.000264
show subpopulations
Gnomad AFR exome
AF:
0.000189
Gnomad AMR exome
AF:
0.000449
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000348
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000309
AC:
445
AN:
1438740
Hom.:
1
Cov.:
49
AF XY:
0.000279
AC XY:
199
AN XY:
714116
show subpopulations
African (AFR)
AF:
0.000122
AC:
4
AN:
32818
American (AMR)
AF:
0.000525
AC:
22
AN:
41920
Ashkenazi Jewish (ASJ)
AF:
0.0000389
AC:
1
AN:
25700
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38256
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83804
European-Finnish (FIN)
AF:
0.0000405
AC:
2
AN:
49366
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4846
European-Non Finnish (NFE)
AF:
0.000362
AC:
399
AN:
1102614
Other (OTH)
AF:
0.000286
AC:
17
AN:
59416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.534
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000263
AC:
40
AN:
152240
Hom.:
0
Cov.:
33
AF XY:
0.000282
AC XY:
21
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41556
American (AMR)
AF:
0.000458
AC:
7
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
67986
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000336
Hom.:
0
Bravo
AF:
0.000283
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ExAC
AF:
0.000278
AC:
33

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
not provided (3)
-
1
1
Hereditary cancer-predisposing syndrome (2)
-
1
-
Gorlin syndrome (1)
-
-
1
Gorlin syndrome;C0025149:Medulloblastoma (1)
-
1
-
Medulloblastoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.17
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.00034
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.024
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
0.0
N
PhyloP100
2.5
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
0.16
N
REVEL
Benign
0.11
Sift
Benign
0.13
T
Sift4G
Benign
0.35
T
Polyphen
0.059
B
Vest4
0.20
MVP
0.48
MPC
1.1
ClinPred
0.060
T
GERP RS
4.4
PromoterAI
-0.080
Neutral
Varity_R
0.19
gMVP
0.43
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12780580; hg19: chr10-104263959; COSMIC: COSV64016446; API